Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Healthcare Biotechnology
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > Company to update past 8-months work- a lot in the pipeline
View:
Post by Rezjen on Mar 01, 2021 7:07pm

Company to update past 8-months work- a lot in the pipeline

Read between the lines in Today's NR- as this story unfolds to the market, the world will have a solution for Covid-19 
 

More interesting when Ceo says "We intend to become a leader in the race to find a treatment for COVID-19, and we are well positioned to achieve this goal,”

it sounds they are way ahead in the game and knows exactly what they are doing!


long enjoy the ride!!!

Comment by KILOFINAL on Mar 01, 2021 7:24pm
Agree. Don't think they would have chosen this specific time to launch the new company and business strategy unless they were well on their way to achieving the results they expect 
Comment by PowerofNow on Mar 01, 2021 7:33pm
KILOFINAL WOOW, respect. I remember you from when Manulife was under $10 per share ! Been around the block
Comment by KILOFINAL on Mar 01, 2021 7:39pm
Great to read your posts PowerofNow. Yeah, it's been a long time. 
Claritas Pharmaceuticals Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities